title: Unravelling mitochondrial pathways to Parkinson's disease.
abstract: Mitochondria are essential for cellular function due to their role in ATP production, calcium homeostasis and apoptotic signalling. Neurons are heavily reliant on mitochondrial integrity for their complex signalling, plasticity and excitability properties, and to ensure cell survival over decades. The maintenance of a pool of healthy mitochondria that can meet the bioenergetic demands of a neuron, is therefore of critical importance; this is achieved by maintaining a careful balance between mitochondrial biogenesis, mitochondrial trafficking, mitochondrial dynamics and mitophagy. The molecular mechanisms that underlie these processes are gradually being elucidated. It is widely recognized that mitochondrial dysfunction occurs in many neurodegenerative diseases, including Parkinson's disease. Mitochondrial dysfunction in the form of reduced bioenergetic capacity, increased oxidative stress and reduced resistance to stress, is observed in several Parkinson's disease models. However, identification of the recessive genes implicated in Parkinson's disease has revealed a common pathway involving mitochondrial dynamics, transport, turnover and mitophagy. This body of work has led to the hypothesis that the homeostatic mechanisms that ensure a healthy mitochondrial pool are key to neuronal function and integrity. In this paradigm, impaired mitochondrial dynamics and clearance result in the accumulation of damaged and dysfunctional mitochondria, which may directly induce neuronal dysfunction and death. In this review, we consider the mechanisms by which mitochondrial dysfunction may lead to neurodegeneration. In particular, we focus on the mechanisms that underlie mitochondrial homeostasis, and discuss their importance in neuronal integrity and neurodegeneration in Parkinson's disease.
authors.affiliation: MRC Toxicology Unit, Leicester, UK.
authors.forename: I
authors.initials: I
authors.lastname: Celardo
authors.forename: L M
authors.initials: LM
authors.lastname: Martins
authors.forename: S
authors.initials: S
authors.lastname: Gandhi
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D004272:DNA, Mitochondrial / Q000235:genetics; D006706:Homeostasis; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000503:physiopathology; D028361:Mitochondrial Diseases / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D063154:Mitochondrial Dynamics / Q000502:physiology*; D063269:Mitochondrial Turnover / Q000235:genetics / Q000502:physiology*; D063306:Mitophagy / Q000502:physiology*; D008954:Models, Biological; D009410:Nerve Degeneration / Q000150:complications / Q000503:physiopathology*; D009474:Neurons / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D010300:Parkinson Disease / Q000150:complications / Q000235:genetics / Q000503:physiopathology*
chemical_list: D004272:DNA, Mitochondrial; D002118:Calcium
keywords: PARKIN; PINK1; Parkinson's disease; calcium; free radicals; mitochondria; mitophagy; oxidative stress; respiratory chain